We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
3776
DELISTED
Inozyme Pharma
INZY
| $147K | ﹤0.01% |
+28,093
| New | +$146K |
|
3777
Sasol
SSL
$7.58B
| $146K | ﹤0.01% |
+21,649
| New | +$161K |
|
|
MRC
3778
DELISTED
MRC Global
MRC
| $145K | ﹤0.01% |
+11,393
| New | +$147K |
|
3779
Gossamer Bio
GOSS
$66.5M
| $145K | ﹤0.01% |
+146,957
| New | +$141K |
|
3780
PUT
Freshworks
FRSH
$2.84B
| $145K | ﹤0.01% |
12,600
-30,200
| -71% | -$362K |
|
3781
Stoneridge
SRI
$209M
| $143K | ﹤0.01% |
12,793
-7,872
| -38% | -$112K |
|
|
ENFN
3782
DELISTED
Enfusion, Inc.
ENFN
| $143K | ﹤0.01% |
15,083
-65,043
| -81% | -$561K |
|
3783
Custom Truck One Source
CTOS
$2.47B
| $141K | ﹤0.01% |
40,906
+19,221
| +89% | +$80.8K |
|
|
BDN
3784
Brandywine Realty Trust
BDN
$551M
| $141K | ﹤0.01% |
25,845
-57,571
| -69% | -$286K |
|
3785
PUT
Annovis Bio
ANVS
$70.6M
| $139K | ﹤0.01% |
17,200
-7,800
| -31% | -$73.1K |
|
3786
Alpha Teknova
TKNO
$266M
| $138K | ﹤0.01% |
+28,597
| New | +$105K |
|
|
NFBK
3787
DELISTED
Northfield Bancorp
NFBK
| $138K | ﹤0.01% |
11,881
+1,481
| +14% | +$17K |
|
|
NKLA
3788
DELISTED
Nikola Corporation Common Stock
NKLA
| $138K | ﹤0.01% |
+30,086
| New | +$223K |
|
3789
Sportsman's Warehouse
SPWH
$43.7M
| $138K | ﹤0.01% |
50,825
-31,562
| -38% | -$75.1K |
|
3790
Lifetime Brands
LCUT
$198M
| $138K | ﹤0.01% |
21,052
+431
| +2% | +$3.17K |
|
3791
Melco Resorts & Entertainment
MLCO
$2.1B
| $137K | ﹤0.01% |
+17,579
| New | +$104K |
|
3792
Lifecore Biomedical
LFCR
$162M
| $137K | ﹤0.01% |
+27,774
| New | +$145K |
|
|
NVNO
3793
CALL
enVVeno Medical
NVNO
$6.94M
| $136K | ﹤0.01% |
+1,160
| New | +$213K |
|
|
PTVE
3794
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $136K | ﹤0.01% |
11,844
-42,711
| -78% | -$490K |
|
3795
Hallador Energy
HNRG
$718M
| $134K | ﹤0.01% |
14,167
-90,623
| -86% | -$644K |
|
3796
DocGo
DCGO
$58.9M
| $133K | ﹤0.01% |
40,039
-184,158
| -82% | -$626K |
|
3797
NatWest
NWG
$71.5B
| $133K | ﹤0.01% |
+14,175
| New | +$126K |
|
3798
PUT
StoneCo
STNE
$2.62B
| $132K | ﹤0.01% |
11,700
-19,000
| -62% | -$242K |
|
3799
UNIFI
UFI
$117M
| $131K | ﹤0.01% |
17,901
-29,708
| -62% | -$187K |
|
3800
PUT
BRC Group Holdings
RILY
$277M
| $131K | ﹤0.01% |
+25,000
| New | +$277K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.